(Q35539458)

8 August 2017

1 reference

title

Role of complement activation in atherosclerosis (English)

1 reference

8 August 2017

1 reference

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

Cardiology and cardiovascular medicine

12 March 2024

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

12 March 2024

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

12 March 2024

author name string

Riina Oksjoki

1

1 reference

8 August 2017

Petri T. Kovanen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14501586

12 March 2024

Markku O. Pentikäinen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14501586

12 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14501586

12 March 2024

publication date

1 October 2003

1 reference

full work available at URL

8 August 2017

https://journals.lww.com/00041433-200310000-00008

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

Current Opinion in Lipidology

12 March 2024

published in

1 reference

8 August 2017

14

1 reference

8 August 2017

477-482

1 reference

8 August 2017

5

1 reference

Complement activation and atherosclerosis

8 August 2017

1

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

Generation of C-reactive protein and complement components in atherosclerotic plaques

12 March 2024

2

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque

12 March 2024

3

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

Immunohistochemical colocalization of the terminal complex of human complement and smooth muscle cell alpha-actin in early atherosclerotic lesions

12 March 2024

4

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

Immunoelectron-microscopic localization of the terminal C5b-9 complement complex in human atherosclerotic fibrous plaque

12 March 2024

5

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

Immunohistochemical demonstration of enzymatically modified human LDL and its colocalization with the terminal complement complex in the early atherosclerotic lesion

12 March 2024

6

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

Evidence for complement activation in ruptured coronary plaques in acute myocardial infarction

12 March 2024

8

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

Arthritis critically dependent on innate immune system players

12 March 2024

10

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

12 March 2024

11

23

29

Vlaicu

1985

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

12 March 2024

13

163

3957

Jarva

1999

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries

12 March 2024

14

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

Association between complement factor H and proteoglycans in early human coronary atherosclerotic lesions: implications for local regulation of complement activation

12 March 2024

16

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein

12 March 2024

17

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

Binding of C-reactive protein to modified low-density-lipoprotein particles: identification of cholesterol as a novel ligand for C-reactive protein

12 March 2024

18

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

Complement and atherogenesis: binding of CRP to degraded, nonoxidized LDL enhances complement activation

12 March 2024

19

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids

12 March 2024

20

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

C-reactive protein-mediated phagocytosis and phospholipase D signalling through the high-affinity receptor for immunoglobulin G (FcgammaRI).

12 March 2024

21

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

Production of the long pentraxin PTX3 in advanced atherosclerotic plaques

12 March 2024

22

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

Isolation and characterization of a complement-activating lipid extracted from human atherosclerotic lesions

12 March 2024

23

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety

12 March 2024

24

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

Generation of complement anaphylatoxins and C5b-9 by crystalline cholesterol oxidation derivatives depends on hydroxyl group number and position

12 March 2024

25

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

Complement components, but not complement inhibitors, are upregulated in atherosclerotic plaques

12 March 2024

27

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

CD59 (homologous restriction factor 20), a plasma membrane protein that protects against complement C5b-9 attack, in human atherosclerotic lesions

12 March 2024

28

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

12 March 2024

29

127

576

Bhakdi

1981

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

Immunoelectron-microscopic localization of S-protein/vitronectin in human atherosclerotic wall

12 March 2024

30

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

Activation of the human terminal complement pathway in atherosclerosis

12 March 2024

31

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

Complement-dependent clearance of apoptotic cells by human macrophages

12 March 2024

33

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

Mechanisms of phagocytosis in macrophages

12 March 2024

34

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

CD11b/CD18 mediates production of reactive oxygen species by mouse and human macrophages adherent to matrixes containing oxidized LDL.

12 March 2024

35

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

Mechanisms of signal transduction activated by sublytic assembly of terminal complement complexes on nucleated cells

12 March 2024

36

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

12 March 2024

37

137

1286

Seeger

1986

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

Complement-induced release of monocyte chemotactic protein-1 from human smooth muscle cells. A possible initiating event in atherosclerotic lesion formation

12 March 2024

40

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

Sublytic C5b-9 induces proliferation of human aortic smooth muscle cells: role of mitogen activated protein kinase and phosphatidylinositol 3-kinase

12 March 2024

41

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells

12 March 2024

42

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity

12 March 2024

44

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

12 March 2024

45

155

1434

Kilgore

1995

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

12 March 2024

46

142

173

Arend

1989

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

12 March 2024

48

156

3455

Takabayashi

1996

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

Both C3a and C3a(desArg) regulate interleukin-6 synthesis in human peripheral blood mononuclear cells.

12 March 2024

49

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

12 March 2024

50

162

4018

Nataf

1999

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release

12 March 2024

51

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

C5a-induced expression of P-selectin in endothelial cells

12 March 2024

52

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro. Comparison with secretion of interleukin 1 beta and interleukin 1 alpha

12 March 2024

53

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

12 March 2024

54

123

2511

McCarthy

1979

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

12 March 2024

55

130

1257

Morgan

1983

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

Distinct tissue site-specific requirements of mast cells and complement components C3/C5a receptor in IgG immune complex-induced injury of skin and lung

12 March 2024

56

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease

12 March 2024

57

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

Acta Pathologica et Microbiologica Scandinavica. Section A, Pathology

12 March 2024

58

78

284

Geertinger

1970

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

Complement C6 deficiency protects against diet-induced atherosclerosis in rabbits

12 March 2024

60

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

ApoE(-/-) mice develop atherosclerosis in the absence of complement component C5.

12 March 2024

61

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

Influence of C3 deficiency on atherosclerosis

12 March 2024

62

1 reference

https://api.crossref.org/works/10.1097/00041433-200310000-00008

12 March 2024

Identifiers

1 reference

8 August 2017

1 reference